164
Participants
Start Date
February 10, 2020
Primary Completion Date
November 30, 2020
Study Completion Date
December 31, 2020
Questionnaires
The survey will focus on non-valvular atrial fibrillation patients, who will start treatment with a NOAC, and their treating physician.
Many locations, Multiple Locations
Lead Sponsor
Bayer
INDUSTRY